avaliação da resistência insulínica na síndrome de turner ...

33. El Abd S, Patton MA, Turk J, Hoey H, Howlin P. Social, communicational, and
behavioral deficits associated with ring X turner syndrome. Am J Med Genet 1999;
88:510-6.
34. Gøtzsche CO, Krag-Olsen B, Nielsen J, Sorensen KE, Kristensen BO. Prevalence of
cardiovascular malformations and association with karyotypes in Turner’s syndrome.
Arch Dis Child 1994; 71:433–436.
35. Sybert VP. Cardiovascular malformations and complications in Turner syndrome.
Pediatrics 1998; 101:E11.
36. Lin AE, Lippe B, Rosenfeld R. Further delineation of aortic dilation, dissection, and
rupture in patients with Turner syndrome. Pediatrics 1998; 102:E12.
37. Mazzanti L, Cacciari E, Italian Study Group for Turner Syndrome. Congenital heart
disease in patients with Turner syndrome. J Pediatr 1998; 133:688–692.
38. Gravholt CH. Epidemiological, endocrine and metabolic features in Turner
syndrome. Arq Bras Endocrinol Metabol 2005; 49:145-56.
39. Gravholt CH, Naeraa RW, Nyholm B, Gerdes LU, Christiansen E, Schmitz O, et al.
Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult
Turner's syndrome. The impact of sex hormone replacement. Diabetes Care 1998;
21:1062-70.
40. Radetti G, Mazzanti L, Paganini C, Bernasconi S, Russo G, Rigon F, Cacciari E.
Frequency, clinical and laboratory features of thyroiditis in girls with Turner’s
syndrome. Acta Paediatr 1995; 84:909-912.
41. American Association of Clinical Endocrinologists Growth Hormone Task Force.
American Association of Clinical Endocrinologists medical guidelines for clinical
practice for growth hormone use in adults and children - 2003 update. Endocr Pract
2003; 9:64-76
42. Consensus Development Conference on Insulin Resistance. 5-6 November 1997.
American Diabetes Association. Diabetes Care 1998; 21:310-4.
60
60